Activity monitoring in adolescents and young adults with inflammatory rheumatic musculoskeletal diseases (ActiMON)

• Conditions: M33.0; M08.0; M08.2; M08.4; M08.8; M08.3; M32.9; Juvenile dermatomyositis; Juvenile rheumatoid arthritis; Juvenile arthritis with systemic onset

• Registration Number: DRKS00022258
• Lead Sponsor: Deutsches Rheuma-Forschungszentrum Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-18
• Study Completion: 2024-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Age = 12 to 20 years; diagnosed patients with JIA, jDM, jSLE; duration of diagnosis =6 months; physician's global assessment of disease activity < 4 (numerical rating scale 0-10); existence of a declaration of consent to participate in ActiMON and the national padiatric rheumatological database

Exclusion Criteria

recent surgery that temporarily impairs activity behavior; neurological, cardiac or lung disease that limits physical activity, cortisone treatment > 0.2 mg/kg body weight or > 10mg/day within the last 4 weeks; intra-articular steroid injection in the last 4 weeks; pregnant or nursing women; participation in concurrent behavioral or exercise therapy (intervention) studies; insufficient knowledge of German, which precludes understanding the study information

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment of physical activity behavior among young rheumatics. Identification of a) barriers to physical activity and b) risk groups for physical inactivity. Derivation of measures to promote physical activity.

Secondary Outcome Measures

Name	Time	Method
Parameters of the questionnaires (e.g. quality of life, media consumption, social support) at time of investigation.